Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Bonferroni Test01:10

Bonferroni Test

The Bonferroni test is a statistical test named after Carlo Emilio Bonferroni, an Italian mathematician best known for Bonferroni inequalities. This statistical test is a type of multiple comparison test to determine which means are different than the rest. Bonferroni test can minimize the Type 1 error by reducing the significance level alpha, which otherwise increases with sample pairs.
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimation of exponential rates in non-homogeneous populations using the EAIR estimator.

Journal of biopharmaceutical statistics·2026
Same author

The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis.

Kidney international·2025
Same author

Estimand Framework and Statistical Considerations for Integrated Analysis of Clinical Trial Safety Data.

Therapeutic innovation & regulatory science·2024
Same author

Mixture-based gatekeeping procedures in adaptive clinical trials.

Journal of biopharmaceutical statistics·2017
Same author

An enhanced mixture method for constructing gatekeeping procedures in clinical trials.

Journal of biopharmaceutical statistics·2017
Same author

Consistency-ensured parametric tests for critical events of composite endpoints.

Journal of biopharmaceutical statistics·2017

Related Experiment Video

Updated: Jun 10, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Method of balanced adjustment in testing co-primary endpoints.

George Kordzakhia1, Ohidul Siddiqui, Mohammad F Huque

  • 1Division of Biometrics I, Office of Biostatistics, CDER, FDA, Silver Spring, MD 20993, USA. George.Kordzakhia@fda.hhs.gov

Statistics in Medicine
|August 5, 2010
PubMed
Summary

Clinical trials with multiple co-primary endpoints risk increased type II errors. This study introduces a compromise testing approach to manage statistical significance and control false positive rates, potentially reducing sample size needs.

Related Experiment Videos

Last Updated: Jun 10, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Statistical Methods

Background:

  • Multiple co-primary endpoints in clinical trials can inflate Type II error rates, necessitating larger sample sizes.
  • Existing methods for adjusting significance levels (e.g., Patel, 1991; Chuang-Stein et al., 2007) have limitations, particularly when treatment effects are small or individual hypothesis significance is not paramount.

Purpose of the Study:

  • To introduce a novel compromise testing approach for clinical trials with multiple co-primary endpoints.
  • To control the maximum joint false positive rate within a restricted null space.
  • To offer an alternative when individual statistical significance for each endpoint is not strictly required.

Main Methods:

  • A compromise testing strategy is proposed where significance levels are adjusted upward for co-primary endpoints.
  • Adjustment is contingent on demonstrating high statistical significance for one or more other co-primary endpoints.
  • The method incorporates endpoint correlations, requiring larger adjustments for smaller correlations, and is applicable to restricted null spaces.

Main Results:

  • The proposed approach effectively controls the maximum joint false positive rate over the restricted null space.
  • This method offers a way to manage Type II error inflation without necessarily demanding excessively large sample sizes.
  • The adjustment mechanism is sensitive to the correlation structure among co-primary endpoints.

Conclusions:

  • The compromise testing approach provides a viable statistical framework for clinical trials with multiple co-primary endpoints.
  • It offers a flexible alternative to traditional methods, especially when seeking to balance statistical power and sample size.
  • This method enhances the management of statistical errors in complex trial designs.